Ordering Recommendation

May be used to screen for inflammatory bowel disease (IBD) versus irritable bowel syndrome (IBS).

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Stool.

Specimen Preparation

Transfer 5 g stool to an unpreserved stool transport vial (ARUP supply #40910). Available online through eSupply using ARUP Connect™ or contact Client Services at (800) 522-2787. (Min: 1 g) Also acceptable: Place 5 g stool in enteric transport media (Cary-Blair) (ARUP Supply #29799). Available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787.

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Specimens in any transport media than indicated above.

Remarks
Stability

Unpreserved: Ambient: 2 weeks; Refrigerated: 2 weeks; Frozen: 2 weeks
Preserved:
Ambient: 1 week; Refrigerated: 2 weeks; Frozen: 2 weeks

Methodology

Qualitative Enzyme-Linked Immunosorbent Assay

Performed

Sun-Sat

Reported

1-2 days

Reference Interval

Negative

Interpretive Data

A positive result is indicative of the presence of lactoferrin, a marker for fecal leukocytes.  A negative result does not exclude the presence of intestinal inflammation.

Compliance Category

FDA

Note

Hotline History

N/A

CPT Codes

83630

Components

Component Test Code* Component Chart Name LOINC
0061164 Lactoferrin, Fecal by ELISA 40703-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Fecal Lactoferrin
  • Fecal Leukocytes
  • Fecal WBC Non-microscopic
  • Stool Lactoferrin
Lactoferrin, Fecal by ELISA